Sunil Agarwal

Chief Medical Officer, Ultragenyx Pharmaceutical Inc.

Companies

Catabasis PharmaceuticalsBoard member Apr 9, 2024 to now¹
Arvinas (United States)Board member Jun 20, 2023 to now²
Calithera Biosciences, Inc.Board member Sep 30, 2015 to Jun 3, 2022³
Sana BiotechnologyOfficer Feb 3, 2021 to Mar 8, 2022⁴
Ultragenyx Pharmaceutical Inc.Chief Medical Officer Aug 21, 2014 to Aug 23, 2016⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arvinas (United States) ARVN30,166 shares⁶$216.7K at $7.18Jun 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 25, 2025Granted 16,025 shares of Arvinas (United States)⁶
May 29, 2024Granted 5,899 shares of Arvinas (United States)⁷
Jun 15, 2023Granted 8,242 shares of Arvinas (United States)⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCatabasis Pharmaceuticals, Board member
2
SEC EDGARArvinas (United States), Board member
3
SEC EDGARCalithera Biosciences, Inc., Board member
4
SEC EDGARSana Biotechnology, Officer
5
SEC EDGARUltragenyx Pharmaceutical Inc., Chief Medical Officer
6
SEC EDGARArvinas (United States) shares after the filing of Jun 25, 2025
7
SEC EDGARForm 4 filed May 31, 2024
8
SEC EDGARForm 4 filed Jun 20, 2023